Bellodi L, Erzegovesi S, Bianchi L, Lucini V, Conca R, Lucca A
Department of Neuropsychiatric Sciences, Istituto Scientifico Ospedale San Raffaele, University of Milan School of Medicine, Italy.
Psychiatry Res. 1997 Mar 3;69(1):9-15. doi: 10.1016/s0165-1781(96)02961-7.
We have studied fasting plasma tryptophan (TRP) levels and tryptophan/large neutral amino acid (TRP/LNAA) ratios in 12 patients with obsessive-compulsive disorder (OCD) and 12 patients with OCD and a coexisting current diagnosis of major depressive disorder (OCD-MDD). Assessments were made at baseline and after 6 weeks of treatment with fluvoxamine. OCD-MDD patients had significantly lower baseline TRP levels and TRP/LNAA ratios than OCD patients. After 6 weeks of fluvoxamine treatment, OCD-MDD patients had significant increases in plasma TRP and TRP/LNAA ratio, whereas OCD patients had non-significant decreases. Our data suggest that a major depressive syndrome could be a state variable affecting the changes in plasma TRP and TRP/LNAA ratio in OCD patients.
我们研究了12例强迫症(OCD)患者以及12例同时患有强迫症和当前重性抑郁障碍诊断(OCD-MDD)的患者的空腹血浆色氨酸(TRP)水平和色氨酸/大中性氨基酸(TRP/LNAA)比值。在基线时以及使用氟伏沙明治疗6周后进行评估。OCD-MDD患者的基线TRP水平和TRP/LNAA比值显著低于OCD患者。经过6周的氟伏沙明治疗后,OCD-MDD患者的血浆TRP和TRP/LNAA比值显著升高,而OCD患者则有非显著性降低。我们的数据表明,重性抑郁综合征可能是一个影响OCD患者血浆TRP和TRP/LNAA比值变化的状态变量。